Developer docs
API playgroundTry for free, no card

Search company profiles

Raysearch Laboratories

Full company profile

uuid0000p8o

Namestring
Raysearch Laboratories
Legal namestring
RaySearch Laboratories AB (publ)
Company typeenum
Public
Founded yearint
2000
Descriptiontext

RaySearch Laboratories AB (publ) is a Swedish medical technology company founded in 2000 as a spin-off from the Karolinska Institute, headquartered in Stockholm and listed on Nasdaq Stockholm under RAY B since 2003. The company develops software for radiation oncology, organized around four core platforms: RayStation (treatment planning system), RayCare (oncology information system), RayCommand (treatment control system), and RayIntelligence (oncology analytics system). Its software supports photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy (BNCT), with advanced optimization algorithms (originating in the ORBIT code from Karolinska research since 1985), GPU-accelerated Monte Carlo dose computation, multi-criteria optimization, deformable image registration, and adaptive radiotherapy.

RaySearch's product portfolio is differentiated by a vendor-agnostic architecture that integrates with treatment machines from Varian, Elekta, Accuray, Mevion, IBA, Hitachi, Canon Medical, United Imaging Healthcare, and others, plus DICOM interoperability and the UniteRT consortium. The company pioneered the first machine learning applications inside a treatment planning system (RayStation 8B, 2018) and now embeds deep learning segmentation, knowledge-based automated planning (ECHO), and adaptive radiotherapy (ARTemis) across the suite. A complementary image-guided Liver Ablation Module was co-developed with MD Anderson Cancer Center, and the company entered chemotherapy quality assurance through the February 2024 acquisition of DrugLog from Pharmacolog.

The business model is enterprise software: primarily perpetual and subscription licenses for treatment planning and oncology information systems sold to hospitals, cancer centers, and proton/ion therapy facilities, supplemented by professional services (implementation, training, support). Distribution is direct via Regional Business Directors across all major geographies with local distribution partners in markets such as Vietnam, Russia, Italy, Poland, Thailand, Indonesia, and Brazil. Reported full-year 2025 net sales were SEK 1,340 million (~13% YoY growth) with Q4 2025 net sales of SEK 375 million (~16% YoY) and a 24% operating profit margin; installed base covers 1,200+ clinics in 51 countries.

Short descriptiontext

RaySearch Laboratories is a Swedish medical software company that develops vendor-agnostic treatment planning, oncology information, treatment control, and analytics systems used by more than 1,200 cancer clinics across 51 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiation oncology software, treatment planning systems, oncology information systems, particle therapy planning, adaptive radiotherapy software
Industry2 codes
1Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
CodeHLAHABAHPrimaryYes
2Radiation Dose Management & Analytics
CodeHLACALAHPrimaryNo
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Radiation Oncology Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Software Licenses and Subscriptions
TypeSubscription Recurring
Description

RaySearch generates revenue primarily through the sale of software licenses for RayStation treatment planning system, RayCare oncology information system, and related products. The software is sold to hospitals and cancer treatment centers globally.

raysearchlabs.com
2Professional Services
TypeProfessional Services
Description

Implementation, training, and support services provided alongside software deployments.

raysearchlabs.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1RayStation
Description

Treatment planning system (TPS) supporting photon, electron, proton, carbon ion, and other radiation therapy techniques with advanced optimization and machine learning capabilities.

raysearchlabs.com
+6 more records
Core offering1 text field

RaySearch Laboratories develops and sells vendor-neutral software for radiation therapy and oncology. Its portfolio includes RayStation, a flagship treatment planning system supporting photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy; RayCare, an oncology information system for workflow management; RayCommand, a treatment control system linking treatment machines with planning and information systems; and RayIntelligence, an oncology analytics system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Simulation to treatment planning time reduced from seven days to seven minutes with GE HealthCare iRT integration
+2 more records
Product overview1 text field

RaySearch Laboratories is a medical technology company developing software solutions for cancer treatment. The product portfolio consists of four core platforms: RayStation (treatment planning system), RayCare (oncology information system), RayCommand (treatment control system), and RayIntelligence (oncology analytics system). RayStation is the flagship treatment planning system supporting photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy (BNCT), with advanced features including automated planning, machine learning, multi-criteria optimization, and adaptive therapy. RayCare manages oncology workflows including scheduling, patient charts, and treatment management across enterprise deployments. RayCommand links treatment machines with planning and information systems, while RayIntelligence provides data analytics capabilities. Additional offerings include the Liver Ablation Module for image-guided procedures, RayImaging radiology workstation, RayCare PACS, RayMigrate for data migration, and the acquired DrugLog product for chemotherapy quality assurance. Micro RayStation serves pre-clinical research needs. The company also offers specialized modules like ECHO for automated proton planning, ARTemis for online adaptive radiotherapy, and Plan Explorer for treatment plan comparison. RaySearch software has been sold to over 1,200 clinics in 51 countries.

Product and service9 records
1RayStation
CategoryTreatment Planning System
Description

Flagship treatment planning system (TPS) supporting photon, electron, proton, carbon ion, and boron neutron capture therapy (BNCT) with automated planning, machine learning, multi-criteria optimization, robust optimization, adaptive therapy, and integration with treatment delivery systems from multiple vendors. Sold to hospitals and cancer treatment centers globally.

2RayCare
CategoryOncology Information System
Description

Oncology information system (OIS) designed to coordinate and manage radiation oncology workflows across multiple clinics, providing scheduling, patient chart management, treatment planning efficiency tools, treatment management, PACS integration, and enterprise-wide connectivity.

3RayCommand
CategoryTreatment Control System
Description

Treatment control system (TCS) designed to link the treatment machine with treatment planning and oncology information systems, enabling coordinated treatment delivery.

4RayIntelligence
CategoryOncology Analytics System
Description

Oncology analytics system (OAS) enabling cancer clinics to collect, structure, and analyze data for insights into treatment outcomes and operational efficiency.

5RayPlan
CategoryTreatment Planning System
Description

Legacy treatment planning system offering within the RaySearch product portfolio.

6Micro RayStation
CategoryResearch Treatment Planning
Description

Version of the RayStation treatment planning system designed for pre-clinical research applications.

7DrugLog
CategoryChemotherapy Quality Assurance
Description

Chemotherapy quality assurance product acquired from Pharmacolog, supporting verification of chemotherapy drug preparation.

8RayMigrate
CategoryData Migration Software
Description

Standalone data migration tool enabling transfer of patient and treatment data between different treatment planning systems.

9Liver Ablation Module
CategoryImage-Guided Ablation Software
Description

Image-guided liver ablation module developed in collaboration with MD Anderson Cancer Center, supporting pre-ablation planning, real-time needle guidance, and post-treatment verification using AI tools.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-29
Description

Iridium Network invested in RayCare, becoming their primary oncology information system and actively contributing to its development. The partnership aims to standardize and automate radiation oncology workflows across multiple hospital clinics in Antwerp, Belgium, with plans for machine learning-powered automation.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

TD Tech Company is RaySearch's distributor in Vietnam, facilitating the introduction of advanced proton therapy at Tam Anh General Hospital.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration to improve radiation oncology treatment planning. GE HealthCare integrated RayStation into its Intelligent Radiation Therapy (iRT) workflow solution, reducing simulation to treatment planning time significantly.

Strategic tierCoreTypeTechnology or Integration
Description

Long-term collaboration agreement signed in 2007 to develop advanced radiotherapy treatment planning. Multiple products launched through the partnership including VMAT and IMRT solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance to offer integrated comprehensive solution for adaptive proton radiation therapy, including development of online adaptive proton workflow demonstrated at ESTRO.

Strategic tierCoreTypeTechnology or Integration
Description

Extended collaboration to support RayCare oncology information system and HYPERSCAN adaptive aperture IMPT capabilities. Joint development of next-generation treatment planning techniques for FLASH proton radiotherapy.

Strategic tierCoreTypeTechnology or Integration
Description

Collaboration agreement for integrated solutions in radiation oncology. Expanded partnership in 2021 for Canon Medical Systems USA.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration on image-guided liver ablation module development. MD Anderson provided clinical expertise for the AI-powered module supporting the entire treatment workflow.

Strategic tierCoreTypeTechnology or Integration
Description

Long-standing partnership for treatment planning software development. Products like P3IMRT and RayBiology integrated into Philips Pinnacle3 system.

Strategic tierCoreTypeTechnology or Integration
Description

Healthcare business group partner in Japan. Annual RaySearch-Hitachi User Meeting hosted. RayStation integrated with Hitachi proton therapy systems.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership announced for surface guided treatment planning integration.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership regarding brachytherapy planning integration.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership to enable upright radiotherapy solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership to shape the future of cancer treatment. First patients treated with machine learning generated plans as part of evaluation study.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Elekta is RaySearch's closest direct competitor, offering Monaco treatment planning system and MOSAIQ oncology information system, alongside its own linear accelerators. Both companies compete head-to-head for radiation oncology software deals at hospitals and proton therapy centers globally.

TypeBroad incumbent
Description

Varian, now part of Siemens Healthineers, offers Eclipse (TPS), ARIA (OIS), and the leading TrueBeam linac franchise. While Varian is a hardware OEM, its software portfolio directly competes with RayStation and RayCare, and its scale (combined with Siemens) gives it bundling power RaySearch must navigate around.

TypeDirect peer
Description

Brainlab provides radiation oncology treatment planning software (iPlan, Elements) and supports multiple linac vendors. Its surgical and radiotherapy software portfolio overlaps directly with RaySearch's planning and image-guided offerings for cancer treatment centers.

TypeBroad incumbent
Description

Philips historically partnered with RaySearch to integrate ORBIT-derived algorithms into its Pinnacle3 TPS and has a broader healthcare imaging portfolio. Philips remains a partial competitor in radiation oncology software while also being a historical technology partner through RayBiology and P3IMRT.

TypeDirect peer
Description

Accuray manufactures CyberKnife and Radixact (TomoTherapy) treatment delivery systems, and historically bundled its own Precision treatment planning software. Accuray competes with RaySearch both as a TPS vendor and as an integrated hardware/software player in radiosurgery and hypofractionated RT.

TypeEmerging player
Description

MIM Software offers medical imaging informatics solutions including MIM Symphony for radiation oncology, with overlap to RaySearch's RayCare PACS and RayIntelligence analytics offerings. MIM is a smaller, specialty competitor focused on imaging workflow and AI-based contouring.

TypeEmerging player
Description

ViewRay pioneered MR-guided radiation therapy with its MRIdian system and integrated treatment planning. It represents a niche competitor in adaptive RT, an area where RaySearch's ARTemis and RayStation are also competing for share of MR-guided and conventional online adaptive workflows.

TypeEmerging player
Description

C-Rad provides surface-guided radiation therapy (SGRT) solutions and Catalyst/BeamCT products. While not a direct TPS competitor, C-Rad's SGRT systems intersect with RaySearch's adaptive RT and surface-guided integration (Vision RT partnership), making it a partial competitor in the advanced RT workflow stack.

TypeEmerging player
Description

Mirada Medical offers radiation treatment planning and medical imaging software with a focus on AI-driven auto-contouring and multimodality image registration. It competes with RaySearch's deep learning segmentation and RayStation adaptive workflow capabilities, particularly in the UK and European markets.

TypeBroad incumbent
Description

GE HealthCare's Intelligent Radiation Therapy (iRT) solution integrates with RayStation and competes in adjacent imaging and simulation workflows. As a broader imaging OEM, GE HealthCare is both a partner (enabling 7-day-to-7-minute workflow gains) and an adjacent incumbent in the radiotherapy ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Raysearch Laboratories

Radiation Oncology Softwareraysearchlabs.com

RaySearch Laboratories is a Swedish medical software company that develops vendor-agnostic treatment planning, oncology information, treatment control, and analytics systems used by more than 1,200 cancer clinics across 51 countries.

What Raysearch Laboratories does

RaySearch Laboratories AB (publ) is a Swedish medical technology company founded in 2000 as a spin-off from the Karolinska Institute, headquartered in Stockholm and listed on Nasdaq Stockholm under RAY B since 2003. The company develops software for radiation oncology, organized around four core platforms: RayStation (treatment planning system), RayCare (oncology information system), RayCommand (treatment control system), and RayIntelligence (oncology analytics system). Its software supports photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy (BNCT), with advanced optimization algorithms (originating in the ORBIT code from Karolinska research since 1985), GPU-accelerated Monte Carlo dose computation, multi-criteria optimization, deformable image registration, and adaptive radiotherapy.

RaySearch's product portfolio is differentiated by a vendor-agnostic architecture that integrates with treatment machines from Varian, Elekta, Accuray, Mevion, IBA, Hitachi, Canon Medical, United Imaging Healthcare, and others, plus DICOM interoperability and the UniteRT consortium. The company pioneered the first machine learning applications inside a treatment planning system (RayStation 8B, 2018) and now embeds deep learning segmentation, knowledge-based automated planning (ECHO), and adaptive radiotherapy (ARTemis) across the suite. A complementary image-guided Liver Ablation Module was co-developed with MD Anderson Cancer Center, and the company entered chemotherapy quality assurance through the February 2024 acquisition of DrugLog from Pharmacolog.

The business model is enterprise software: primarily perpetual and subscription licenses for treatment planning and oncology information systems sold to hospitals, cancer centers, and proton/ion therapy facilities, supplemented by professional services (implementation, training, support). Distribution is direct via Regional Business Directors across all major geographies with local distribution partners in markets such as Vietnam, Russia, Italy, Poland, Thailand, Indonesia, and Brazil. Reported full-year 2025 net sales were SEK 1,340 million (~13% YoY growth) with Q4 2025 net sales of SEK 375 million (~16% YoY) and a 24% operating profit margin; installed base covers 1,200+ clinics in 51 countries.

Raysearch Laboratories firmographics

Firmographics
Name
Raysearch Laboratories
Legal name
RaySearch Laboratories AB (publ)
Website
https://raysearchlabs.com
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
251–500 employees
Short description
RaySearch Laboratories is a Swedish medical software company that develops vendor-agnostic treatment planning, oncology information, treatment control, and analytics systems used by more than 1,200 cancer clinics across 51 countries.
Ownership category
akta.pro rank

Raysearch Laboratories industry classification

Industry
Product category
Radiation Oncology Software
SIC
Services-Computer Programming Services (7371)
akta.pro primary industry
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
akta.pro secondary industry
Radiation Dose Management & Analytics (HLACALAH)

Keywords

  • Radiation oncology software
  • Treatment planning systems
  • Oncology information systems
  • Particle therapy planning
  • Adaptive radiotherapy software

Where Raysearch Laboratories is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Raysearch Laboratories business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Licenses and Subscriptions: RaySearch generates revenue primarily through the sale of software licenses for RayStation treatment planning system, RayCare oncology information system, and related products. The software is sold to hospitals and cancer treatment centers globally.
  2. Professional Services: Implementation, training, and support services provided alongside software deployments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Raysearch Laboratories product offering

Product offering

Core offering

RaySearch Laboratories develops and sells vendor-neutral software for radiation therapy and oncology. Its portfolio includes RayStation, a flagship treatment planning system supporting photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy; RayCare, an oncology information system for workflow management; RayCommand, a treatment control system linking treatment machines with planning and information systems; and RayIntelligence, an oncology analytics system.

Product overview

RaySearch Laboratories is a medical technology company developing software solutions for cancer treatment. The product portfolio consists of four core platforms: RayStation (treatment planning system), RayCare (oncology information system), RayCommand (treatment control system), and RayIntelligence (oncology analytics system). RayStation is the flagship treatment planning system supporting photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy (BNCT), with advanced features including automated planning, machine learning, multi-criteria optimization, and adaptive therapy. RayCare manages oncology workflows including scheduling, patient charts, and treatment management across enterprise deployments. RayCommand links treatment machines with planning and information systems, while RayIntelligence provides data analytics capabilities. Additional offerings include the Liver Ablation Module for image-guided procedures, RayImaging radiology workstation, RayCare PACS, RayMigrate for data migration, and the acquired DrugLog product for chemotherapy quality assurance. Micro RayStation serves pre-clinical research needs. The company also offers specialized modules like ECHO for automated proton planning, ARTemis for online adaptive radiotherapy, and Plan Explorer for treatment plan comparison. RaySearch software has been sold to over 1,200 clinics in 51 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • RayStation: Treatment planning system (TPS) supporting photon, electron, proton, carbon ion, and other radiation therapy techniques with advanced optimization and machine learning capabilities.
  • RayCare
  • RayIntelligence
  • RayCommand
  • RayPlan
  • Micro-RayStation
  • DrugLog

Products and services

  • RayStation Flagship treatment planning system (TPS) supporting photon, electron, proton, carbon ion, and boron neutron capture therapy (BNCT) with automated planning, machine learning, multi-criteria optimization, robust optimization, adaptive therapy, and integration with treatment delivery systems from multiple vendors. Sold to hospitals and cancer treatment centers globally.
  • RayCare Oncology information system (OIS) designed to coordinate and manage radiation oncology workflows across multiple clinics, providing scheduling, patient chart management, treatment planning efficiency tools, treatment management, PACS integration, and enterprise-wide connectivity.
  • RayCommand Treatment control system (TCS) designed to link the treatment machine with treatment planning and oncology information systems, enabling coordinated treatment delivery.
  • RayIntelligence Oncology analytics system (OAS) enabling cancer clinics to collect, structure, and analyze data for insights into treatment outcomes and operational efficiency.
  • RayPlan Legacy treatment planning system offering within the RaySearch product portfolio.
  • Micro RayStation Version of the RayStation treatment planning system designed for pre-clinical research applications.
  • DrugLog Chemotherapy quality assurance product acquired from Pharmacolog, supporting verification of chemotherapy drug preparation.
  • RayMigrate Standalone data migration tool enabling transfer of patient and treatment data between different treatment planning systems.
  • Liver Ablation Module Image-guided liver ablation module developed in collaboration with MD Anderson Cancer Center, supporting pre-ablation planning, real-time needle guidance, and post-treatment verification using AI tools.

Quantifiable outcome

  • Simulation to treatment planning time reduced from seven days to seven minutes with GE HealthCare iRT integration
  • +2 more outcomes

Companies that use Raysearch Laboratories

Customer profile

Named customers10 records

Segments2 records

Ideal customer profiles2 records

Raysearch Laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability8 records

Feature9 records

Raysearch Laboratories partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core.

  • Iridium NetworkcoreStrategic or Co-development Partner · 29 October 2021Iridium Network invested in RayCare, becoming their primary oncology information system and actively contributing to its development. The partnership aims to standardize and automate radiation oncology workflows across multiple hospital clinics in Antwerp, Belgium, with plans for machine learning-powered automation.
  • TD Tech Company (Vietnam)coreChannel Partner/ Reseller/ DistributorTD Tech Company is RaySearch's distributor in Vietnam, facilitating the introduction of advanced proton therapy at Tam Anh General Hospital.
  • GE HealthCarecoreTechnology or IntegrationCollaboration to improve radiation oncology treatment planning. GE HealthCare integrated RayStation into its Intelligent Radiation Therapy (iRT) workflow solution, reducing simulation to treatment planning time significantly.
  • Varian Medical SystemscoreTechnology or IntegrationLong-term collaboration agreement signed in 2007 to develop advanced radiotherapy treatment planning. Multiple products launched through the partnership including VMAT and IMRT solutions.
  • IBA (Ion Beam Applications)coreStrategic or Co-development PartnerStrategic alliance to offer integrated comprehensive solution for adaptive proton radiation therapy, including development of online adaptive proton workflow demonstrated at ESTRO.
  • Mevion Medical SystemscoreTechnology or IntegrationExtended collaboration to support RayCare oncology information system and HYPERSCAN adaptive aperture IMPT capabilities. Joint development of next-generation treatment planning techniques for FLASH proton radiotherapy.
  • Canon Medical SystemscoreTechnology or IntegrationCollaboration agreement for integrated solutions in radiation oncology. Expanded partnership in 2021 for Canon Medical Systems USA.
  • MD Anderson Cancer CentercoreStrategic or Co-development PartnerClinical collaboration on image-guided liver ablation module development. MD Anderson provided clinical expertise for the AI-powered module supporting the entire treatment workflow.
  • Philips Radiation Oncology SystemscoreTechnology or IntegrationLong-standing partnership for treatment planning software development. Products like P3IMRT and RayBiology integrated into Philips Pinnacle3 system.
  • Hitachi High-Tech CorporationcoreTechnology or IntegrationHealthcare business group partner in Japan. Annual RaySearch-Hitachi User Meeting hosted. RayStation integrated with Hitachi proton therapy systems.
  • Vision RTcoreTechnology or IntegrationStrategic partnership announced for surface guided treatment planning integration.
  • Eckert & Ziegler BEBIGcoreTechnology or IntegrationPartnership regarding brachytherapy planning integration.
  • Leo Cancer CarecoreTechnology or IntegrationPartnership to enable upright radiotherapy solutions.
  • Princess Margaret Cancer Centre (Canada)coreStrategic or Co-development PartnerStrategic partnership to shape the future of cancer treatment. First patients treated with machine learning generated plans as part of evaluation study.

Scale indicators9 records

Recent moves6 records

Expansion highlights8 records

Raysearch Laboratories competitors and assessment

Company assessment

Direct peers

  • Elekta: Elekta is RaySearch's closest direct competitor, offering Monaco treatment planning system and MOSAIQ oncology information system, alongside its own linear accelerators. Both companies compete head-to-head for radiation oncology software deals at hospitals and proton therapy centers globally.
  • Brainlab: Brainlab provides radiation oncology treatment planning software (iPlan, Elements) and supports multiple linac vendors. Its surgical and radiotherapy software portfolio overlaps directly with RaySearch's planning and image-guided offerings for cancer treatment centers.
  • Accuray: Accuray manufactures CyberKnife and Radixact (TomoTherapy) treatment delivery systems, and historically bundled its own Precision treatment planning software. Accuray competes with RaySearch both as a TPS vendor and as an integrated hardware/software player in radiosurgery and hypofractionated RT.

Broad incumbents

  • Varian Medical Systems (Siemens Healthineers): Varian, now part of Siemens Healthineers, offers Eclipse (TPS), ARIA (OIS), and the leading TrueBeam linac franchise. While Varian is a hardware OEM, its software portfolio directly competes with RayStation and RayCare, and its scale (combined with Siemens) gives it bundling power RaySearch must navigate around.
  • Philips (Radiation Oncology): Philips historically partnered with RaySearch to integrate ORBIT-derived algorithms into its Pinnacle3 TPS and has a broader healthcare imaging portfolio. Philips remains a partial competitor in radiation oncology software while also being a historical technology partner through RayBiology and P3IMRT.
  • GE HealthCare: GE HealthCare's Intelligent Radiation Therapy (iRT) solution integrates with RayStation and competes in adjacent imaging and simulation workflows. As a broader imaging OEM, GE HealthCare is both a partner (enabling 7-day-to-7-minute workflow gains) and an adjacent incumbent in the radiotherapy ecosystem.

Emerging players

  • MIM Software: MIM Software offers medical imaging informatics solutions including MIM Symphony for radiation oncology, with overlap to RaySearch's RayCare PACS and RayIntelligence analytics offerings. MIM is a smaller, specialty competitor focused on imaging workflow and AI-based contouring.
  • ViewRay (MRIdian): ViewRay pioneered MR-guided radiation therapy with its MRIdian system and integrated treatment planning. It represents a niche competitor in adaptive RT, an area where RaySearch's ARTemis and RayStation are also competing for share of MR-guided and conventional online adaptive workflows.
  • C-Rad: C-Rad provides surface-guided radiation therapy (SGRT) solutions and Catalyst/BeamCT products. While not a direct TPS competitor, C-Rad's SGRT systems intersect with RaySearch's adaptive RT and surface-guided integration (Vision RT partnership), making it a partial competitor in the advanced RT workflow stack.
  • Mirada Medical: Mirada Medical offers radiation treatment planning and medical imaging software with a focus on AI-driven auto-contouring and multimodality image registration. It competes with RaySearch's deep learning segmentation and RayStation adaptive workflow capabilities, particularly in the UK and European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Raysearch Laboratories social profiles

Digital presence

Raysearch Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Raysearch Laboratories leadership team

Management profile

Number of profiles

Profiles12 records

Raysearch Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Raysearch Laboratories funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Raysearch Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Raysearch Laboratories

What does Raysearch Laboratories do?

RaySearch Laboratories develops and sells vendor-neutral software for radiation therapy and oncology. Its portfolio includes RayStation, a flagship treatment planning system supporting photon, electron, proton, carbon ion, helium ion, and boron neutron capture therapy; RayCare, an oncology information system for workflow management; RayCommand, a treatment control system linking treatment machines with planning and information systems; and RayIntelligence, an oncology analytics system.

Is Raysearch Laboratories a public or private company?

Raysearch Laboratories is a public company. It is classified as public and is currently operating.

When was Raysearch Laboratories founded?

Raysearch Laboratories was founded in 2000. It employs 251 to 500 people.

Where is Raysearch Laboratories based?

Raysearch Laboratories is headquartered in Stockholm, Sweden, in the Europe region.

How does Raysearch Laboratories make money?

Two revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are professional Services.

Who are Raysearch Laboratories's main competitors?

Direct peers on record are Elekta, Brainlab and Accuray. Broad incumbents are Varian Medical Systems (Siemens Healthineers), Philips (Radiation Oncology) and GE HealthCare. Emerging players are MIM Software, ViewRay (MRIdian), C-Rad and Mirada Medical.

Does Raysearch Laboratories have an API?

No public API is recorded for Raysearch Laboratories.

What industry is Raysearch Laboratories in?

Raysearch Laboratories's product category is Radiation Oncology Software. Its primary akta.pro industry code is HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim), with a secondary code of HLACALAH, Radiation Dose Management & Analytics. Its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dagens industriRobur vräkte ut aktier i blankarfavoriten i septemberSwedbank Robur sold Raysearch shares in September, halving its stake to the lowest level in over a decade. The sale followed earlier disposals, leaving the bank with a significantly reduced position in the French company.Dagens industriRaysearch i nytt IAEA-samarbeteRaysearch, a medical technology company, signed an agreement with the International Atomic Energy Agency (IAEA) to join the Rays of Hope initiative. The announcement was made in a press release from Raysearch.MarketScreenerRaySearch systems go live in clinical operations at new US radiation therapy clinicRaySearch systems went live in clinical operations at a new US radiation therapy clinic, with first treatments in mid-August. The solution combines RaySearch's oncology information and treatment planning systems with the Varian TrueBeam machine. ART selected RaySearch's systems in 2025 and will serve as a US reference center for the integrated solution.BioSpaceAccuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray’s Online Adaptive CapabilitiesAccuray and RaySearch signed a definitive agreement to integrate RayStation treatment planning software with Accuray's radiation therapy platforms, focusing on Radixact and later CyberKnife. Accuray will purchase RayStation licenses totaling $8 million to support online adaptive radiation therapy, which adjusts treatment plans before delivery based on patient anatomy.MarketScreenerRaySearch lands $8m order as it expands Accuray partnershipAccuray agreed to purchase RayStation licenses from RaySearch for $8m, with revenue recognized in 2026. The initial focus is on Radixact, later expanding to CyberKnife. The deal expands their online adaptive radiation therapy collaboration.MorningstarAccuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive CapabilitiesAccuray and RaySearch announced a definitive agreement to integrate RayStation treatment planning software with Accuray's radiation therapy platforms to accelerate online adaptive radiation therapy. Accuray agreed to purchase RayStation licenses with a total order value of $8 million, and the solution will initially focus on the Radixact platform, with future extension to CyberKnife.Dagens industriForskningschef miljonsäljer i RaysearchKjell Eriksson, research director at Raysearch Laboratories, sold 5,500 B-shares for a total of approximately 1.1 million Swedish kronor. The transaction occurred against the backdrop of an analyst's view that the sector is under extreme pressure despite containing interesting companies.Dagens industriStorpost mäklad i RaysearchA large block trade of Raysearch Laboratories shares was internally matched by DNB Carnegie during early Friday trading. The article identifies Johan Löf, the CEO and largest shareholder of Raysearch Laboratories, as a key figure associated with the transaction. This event involves specific financial intermediaries and corporate leadership within the radiation therapy supply sector.Dagens industriRaysearch rapporterar i linje med vinstvarningen: "Naturligtvis inte nöjda"Raysearch reported its quarterly results in line with previous profit warnings, prompting CEO Johan Löf to state that the company is "naturally not satisfied" with the performance. The report confirms a decline in profitability for the period, consistent with earlier corporate guidance. This outcome reflects ongoing operational challenges affecting the company's financial results.Dagens industriRaysearchs siffror i linje med vinstvarningen: ”En besvikelse”Raysearch reported financial results for the second quarter of 2026 that aligned with its previous profit warning. CEO Johan Löf characterized the company's growth and profit development during the quarter as a disappointment.